GlassScriptPhysician profile
Roberto C Santos
NPI 1528262649
$14,083.43
in general payments reported to CMS, 2019-2025
52 companies · $1,147 in 2025
The $1,147 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,408 · 2020: $1,150 · 2021: $1,548 · 2022: $3,585 · 2023: $2,419 · 2024: $2,828 · 2025: $1,147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,653 · Travel and Lodging: $575 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,653.36 |
| Travel and Lodging | $575.28 |
| Education | $164.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $2,273.89 | 2019-2025 | Uptravi, Opsumit |
| Astrazeneca Pharmaceuticals LP | $1,015.00 | 2019-2025 | Fasenra, Tezspire, Andexxa |
| Ethicon INC. | $997.25 | 2022-2025 | Monarch Platform |
| Genzyme Corporation | $879.59 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $723.23 | 2021-2025 | Acthar, Terlivaz |
| Glaxosmithkline, LLC. | $662.96 | 2019-2025 | Nucala, Trelegy Ellipta |
| Philips North America LLC | $633.28 | 2019-2023 | |
| Intuitive Surgical, INC. | $575.28 | 2023 | Da Vinci Surgical System |
| Regeneron Healthcare Solutions, INC. | $517.60 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $515.96 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Jazz Pharmaceuticals INC. | $511.73 | 2020-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $497.92 | 2019-2024 | |
| Harmony Biosciences LLC | $487.38 | 2020-2024 | Wakix |
| Sunovion Pharmaceuticals INC. | $381.06 | 2019-2020 | |
| Mylan Specialty L.P. | $339.38 | 2019-2024 | Yupelri |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $324.59 | 2019-2025 | Arikayce |
| Grifols USA, LLC | $280.52 | 2019-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $240.67 | 2020-2025 | Winrevair |
| Veran Medical Technologies, INC. | $205.74 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $171.39 | 2021-2024 | Glassia |
| Novartis Pharmaceuticals Corporation | $165.91 | 2019-2023 | |
| Amgen INC. | $164.22 | 2022-2025 | Tezspire |
| Gilead Sciences, INC. | $141.66 | 2021-2024 | Veklury |
| Ani Pharmaceuticals, INC. | $130.18 | 2024 | Purified Cortrophin Gel |
| United Therapeutics Corporation | $125.02 | 2021-2023 | Tyvaso |
| Viatris Specialty LLC | $122.34 | 2025 | Yupelri |
| Genentech USA, INC. | $108.16 | 2019-2023 | Xolair |
| Electromed, INC. | $86.33 | 2019-2024 | Smartvest |
| Axsome Therapeutics, INC. | $75.05 | 2023 | Sunosi |
| Medical Device Business Services, INC. | $58.00 | 2024 | Monarch |
| Advanced Respiratory, INC | $55.95 | 2019-2021 | |
| Vifor Pharma, INC. | $53.21 | 2024 | Zemaira |
| Portola Pharmaceuticals, LLC | $46.61 | 2019 | |
| Pulmonx Corporation | $46.03 | 2023-2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Abbvie INC. | $40.93 | 2024 | |
| Verona Pharma, INC. | $39.09 | 2025 | Ohtuvayre |
| Allergan, INC. | $35.32 | 2019 | |
| Inogen, INC. | $35.28 | 2024-2025 | |
| Inspire Medical Systems, INC. | $33.42 | 2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $31.29 | 2021-2022 | |
| Phadia US INC. | $31.14 | 2022-2025 | Immunocap |
| Fisher & Paykel Healthcare INC | $27.79 | 2021-2022 | |
| Astellas Pharma US INC | $27.21 | 2023 | Cresemba |
| Covis Pharma Gmbh | $24.76 | 2022 | |
| Vapotherm INC | $23.50 | 2023 | Vapotherm |
| Shire North American Group INC | $22.49 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $20.60 | 2024 | Lumryz |
| Baxter Healthcare | $18.71 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Biogen, INC. | $16.19 | 2025 | Spinraza |
| Pfizer INC. | $15.06 | 2024 | |
| Zoll Respicardia, INC. | $14.73 | 2023 | Remede System |
| Circassia INC. | $12.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Santos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.